THE POWER OF PSMA
LIVE

Serial Number

79283785

Owner

Telix Pharmaceuticals Limited

Attorney

Andrew S. Ehard

Filing Date

Mar 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

THE POWER OF PSMA Trademark

Serial Number: 79283785 • Registration: 6366701

THE POWER OF PSMA is a trademark filed by Telix Pharmaceuticals Limited on March 3, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Telix Pharmaceuticals Limited (38 trademarks)

Suite 401, 55 Flemington Road

Entity Type: 99

Trademark Details

Filing Date

March 3, 2020

Registration Date

June 1, 2021

Published for Opposition

March 16, 2021

Goods & Services

Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer and also consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringes; drug delivery agents in the form of capsules that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals

Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; medical apparatus for diagnostic radiopharmaceutical use; medical device for treating cancer; diagnostic imaging apparatus for medical use; applicators for pharmaceutical preparations, namely, drug delivery patches sold without medication

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Sep 3, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jul 30, 2026 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 1, 2026 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2026 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Aug 14, 2022 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 11, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 22, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 21, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 1, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 1, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 16, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 16, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 14, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 24, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 10, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 9, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 9, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 9, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 23, 2020 GNRN
NON-FINAL ACTION E-MAILED
Oct 23, 2020 GNRT
NON-FINAL ACTION WRITTEN
Oct 23, 2020 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 22, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 21, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 21, 2020 TROA
REFUSAL PROCESSED BY IB
Jul 18, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 28, 2020 RFCS
REFUSAL PROCESSED BY MPU
Jun 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 29, 2020 RFCR
NON-FINAL ACTION WRITTEN
May 28, 2020 CNRT
ASSIGNED TO EXAMINER
May 20, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
May 2, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 28, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 27, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 23, 2020 REPR